The latest news and research from Diamond Headache Clinic.
Purpose: To see what effect Erenumab has on health and lifestyle, beyond the effect on the number of migraine days each month. Key Criteria: ▪ adults (18-65) with migraines 4 - 20 per month only▪ migraines have at least a moderate impact on fuction▪consistent migraine...
Interventional, randomized, double blind, parallel group, placebo-controlled delayed start study to evaluate the efficacy and safety of eptinezumab in patients with episodic Cluster headache
Purpose: To determine if eptinezumab is a safe and effective treatment for those who suffer from episodic Cluster headache Key Criteria: ▪ adult (18-75) with episodic cluster headache diagnosis ▪ reliable history of previous acute and preventative medication use...
A long term, prospective, observational study to evaluate the safety, including cardiovascular safety, of Fremanezumab in patients with migraine in routine clinical practice
Purpose: To assess the long term safety of fremanezumab and other preventative migraine medications and to assess their effects on the heart and blood vessels Key Criteria: ▪ adult ▪ migraine diagnosis ▪ no previous CGRP prevention medication use ▪ any new migraine...
Trial: A multi-center, open label study assessing the efficacy of Erenumab on functional impact of migraine Purpose: To see what effect Erenumab has on health and lifestyle, beyond the effect on the number of migraine days each month Key Criteria: ▪ adults (18-65)...
Diamond Headache Clinic Inpatient Unit
- (773) 388-6390
- 2900 North Lake Shore Drive
Chicago, IL 60657
* Patients seeking inpatient treatment must be seen and evaluated by a Diamond Headache Clinic physician at one of our outpatient clinics first.